Bruno Rivas Santiago
Bruno Rivas Santiago
Researcher
Verified email at imss.gob.mx
Title
Cited by
Cited by
Year
Expression of Cathelicidin LL-37 during Mycobacterium tuberculosis Infection in Human Alveolar Macrophages, Monocytes, Neutrophils, and Epithelial Cells
B Rivas-Santiago, R Hernandez-Pando, C Carranza, E Juarez, ...
Infection and immunity 76 (3), 935-941, 2008
2622008
Human β-Defensin 2 Is Expressed and Associated with Mycobacterium tuberculosis during Infection of Human Alveolar Epithelial Cells
B Rivas-Santiago, SK Schwander, C Sarabia, G Diamond, ME Klein-Patel, ...
Infection and immunity 73 (8), 4505-4511, 2005
1942005
β-Defensin gene expression during the course of experimental tuberculosis infection
B Rivas-Santiago, E Sada, V Tsutsumi, D Aguilar-León, JL Contreras, ...
The Journal of infectious diseases 194 (5), 697-701, 2006
1082006
Activity of LL-37, CRAMP and antimicrobial peptide-derived compounds E2, E6 and CP26 against Mycobacterium tuberculosis
B Rivas-Santiago, CER Santiago, JE Castañeda-Delgado, ...
International journal of antimicrobial agents 41 (2), 143-148, 2013
1042013
Ability of Innate Defence Regulator Peptides IDR-1002, IDR-HH2 and IDR-1018 to Protect against Mycobacterium tuberculosis Infections in Animal Models
B Rivas-Santiago, JE Castañeda-Delgado, CE Rivas Santiago, ...
PloS one 8 (3), e59119, 2013
1032013
Susceptibility to infectious diseases based on antimicrobial peptide production
B Rivas-Santiago, CJ Serrano, JA Enciso-Moreno
Infection and immunity 77 (11), 4690-4695, 2009
842009
Differential expression of antimicrobial peptides in active and latent tuberculosis and its relationship with diabetes mellitus
I Gonzalez-Curiel, J Castañeda-Delgado, N Lopez-Lopez, Z Araujo, ...
Human immunology 72 (8), 656-662, 2011
782011
Mycobacterium tuberculosis Entry into Mast Cells Through Cholesterol‐rich Membrane Microdomains
S Muñoz, B Rivas‐Santiago, JA Enciso
Scandinavian journal of immunology 70 (3), 256-263, 2009
762009
LL-37 immunomodulatory activity during Mycobacterium tuberculosis infection in macrophages
F Torres-Juarez, A Cardenas-Vargas, A Montoya-Rosales, ...
Infection and immunity 83 (12), 4495-4503, 2015
692015
Induction of β‐defensins by l‐isoleucine as novel immunotherapy in experimental murine tuberculosis
CE Rivas‐Santiago, B Rivas‐Santiago, DA Leon, J Castañeda‐Delgado, ...
Clinical & Experimental Immunology 164 (1), 80-89, 2011
682011
Bacterial expression and antibiotic activities of recombinant variants of human β-defensins on pathogenic bacteria and M. tuberculosis
L Corrales-Garcia, E Ortiz, J Castañeda-Delgado, B Rivas-Santiago, ...
Protein expression and purification 89 (1), 33-43, 2013
652013
Characterization of antibacterial and hemolytic activity of synthetic pandinin 2 variants and their inhibition against Mycobacterium tuberculosis
A Rodríguez, E Villegas, A Montoya-Rosales, B Rivas-Santiago, G Corzo
PloS one 9 (7), e101742, 2014
622014
Expression of antimicrobial peptides in diabetic foot ulcer
B Rivas-Santiago, V Trujillo, A Montoya, I Gonzalez-Curiel, ...
Journal of dermatological science 65 (1), 19-26, 2012
612012
The Potential Role of Lung Epithelial Cells and β‐defensins in Experimental Latent Tuberculosis
B Rivas‐Santiago, JCL Contreras, E Sada, R Hernández‐Pando
Scandinavian journal of immunology 67 (5), 448-452, 2008
612008
1,25-Dihydroxyvitamin D3 Induces LL-37 and HBD-2 Production in Keratinocytes from Diabetic Foot Ulcers Promoting Wound Healing: An In Vitro Model
I Gonzalez-Curiel, V Trujillo, A Montoya-Rosales, K Rincon, ...
PloS one 9 (10), e111355, 2014
542014
Prime-boost BCG vaccination with DNA vaccines based in β-defensin-2 and mycobacterial antigens ESAT6 or Ag85B improve protection in a tuberculosis experimental model
AR Cervantes-Villagrana, R Hernandez-Pando, A Biragyn, ...
Vaccine 31 (4), 676-684, 2013
532013
Peptides from the scorpion Vaejovis punctatus with broad antimicrobial activity
S Ramírez-Carreto, JM Jiménez-Vargas, B Rivas-Santiago, G Corzo, ...
Peptides 73, 51-59, 2015
502015
Kinetics and cellular sources of cathelicidin during the course of experimental latent tuberculous infection and progressive pulmonary tuberculosis
J Castañeda‐Delgado, R Hernández‐Pando, CJ Serrano, ...
Clinical & Experimental Immunology 161 (3), 542-550, 2010
422010
Péptidos antimicrobianos en la inmunidad innata de enfermedades infecciosas
B Rivas-Santiago, E Sada, R Hernández-Pando, V Tsutsumi
salud pública de méxico 48, 62-71, 2006
422006
Type-2 diabetes alters the basal phenotype of human macrophages and diminishes their capacity to respond, internalise, and control Mycobacterium tuberculosis
N Lopez-Lopez, AGR Martinez, MH Garcia-Hernandez, ...
Memórias do Instituto Oswaldo Cruz 113 (4), 2018
342018
The system can't perform the operation now. Try again later.
Articles 1–20